Abstract Invasive pulmonary aspergillosis (IPA) is a life-threatening complication of chronic granulomatous disease (CGD), a rare inherited disorder of phagocytes that is characterized by a defect in the production of reactive oxygen species (ROS) caused by mutations in NADPH oxidase 2. Here, we report a case of successful treatment of IPA complicated with CGD by the administration of interferon-c (IFN-c) in combination with voriconazole. The patient carried a splice site mutation in the CYBB gene, and the neutrophils could produce a certain amount of ROS. In this case, augmentation of ROS generation in the patient's neutrophils was observed after in vivo IFN-c treatment, which may be attributable to the induction of a normal CYBB gene in the myeloid progenitor cells. This treatment, in combination with voriconazole, may have contributed to the reversal of IPA in this patient. These results suggest that the in vivo use of IFN-c may augment ROS generation in CGD neutrophils, thus leading to the successful treatment of severe IPA.
Introduction
Chronic granulomatous disease (CGD) is a rare inherited disorder caused by mutations in NADPH oxidase 2 (Nox2) of phagocytes. CGD neutrophils show a defect in the production of reactive oxygen species (ROS), leading to recurrent bacterial and fungal infections. Mutations in 5 genes (CYBB, CYBA, NCF1, NCF2, NCF4) have been reported to cause CGD [1] . Mutations of CYBB in Xp21.1, which codes for gp91 phox , also known as Nox2, account for almost 80 % of CGD in Japan. Mutations in the CYBB gene, which encompasses 13 exons, are heterogeneous, including missense and nonsense mutations, deletions, insertions, and splice site mutations [2] . The use of various cytokines has been attempted to enhance the ability of ROS generation of CGD neutrophils. A previous report demonstrated that interferon (IFN)-c improved the superoxidegenerating ability by changing the splicing pattern of transcripts in CGD neutrophils with a splice site mutation (G to A point mutation at nucleotide 252 in exon 3) in the CYBB gene [3] .
Invasive pulmonary aspergillosis (IPA) is one of the life-threatening complications of CGD, since ROS play a critical role in killing Aspergillus hyphae. Voriconazole, which is a triazole antifungal medication, has become the standard treatment for IPA. However, it leads to an insufficient response in some CGD cases, for instance, because of the emergence of multi-azole-resistant Aspergillus [4] . On the other hand, a previous observation showed that treatment with human recombinant IFNc augmented the ability of CGD neutrophils to generate ROS, resulting in decreased susceptibility to bacterial and fungal infections [5] . In addition, it was reported that in vivo IFN-c therapy augmented the in vitro ability of CGD neutrophils to kill Aspergillus hyphae [6] .
Therefore, IFN-c treatment is expected to exert an additive therapeutic effect on the CGD patients in critical conditions.
We recently encountered a CGD patient with a splicing site mutation in the CYBB gene, who was complicated by severe IPA. In this case, IFN-c treatment in combination with voriconazole markedly improved the symptoms and clinical data. We observed the enhancement of ROS production of the CGD neutrophils after IFN-c treatment as revealed by flow cytometric analysis, possibly contributing to the successful killing of Aspergillus.
Case report
A 26-year-old Japanese male was admitted to our hospital because of fever, cough, and dyspnea on 29 August 2007 (day 0). He had been exposed to a large amount of dirty dust 3 days before the admission. He had been diagnosed with gp91
phox -deficient CGD in his early childhood by gene mutational analysis. It revealed a G to A point mutation at nucleotide 252 in exon 3 of the CYBB gene, which produces an aberrant splice donor site in exon 3 (Ggt to Agt), as previously described [3] . He had suffered from recurrent bacterial infections, such as meningitis and pneumonia from his early childhood. His maternal grandfather and cousin were also CGD patients. On admission, his temperature was 37.3°C and percutaneous oxygen saturation was 78 % under room air. Coarse crackles were heard in the bilateral lung fields. Laboratory data are shown in Table 1 . Neutrophilic leukocytosis and elevation of the CRP value were observed. On admission, chest X-ray film showed bilateral infiltrations (Fig. 1a) , and a chest CT scan demonstrated diffuse small granular opacities and consolidations in a lobular-centric manner in the bilateral lung fields, suggesting military tuberculosis (Fig. 1b) . Bronchial alveolar lavage (BAL) showed Aspergillus fumigatous (1?), and the quantitative analysis of Aspergillus was 3 9 10 5 copies/ml. The polymerase chain reactions (PCR) for Mycobacterium (M) tuberculosis, M. avium complex, and M. intracellulare DNAs were all negative in BAL, bone marrow, and gastric fluid specimens. The serum b-D glucan level was Moreover, treatment with a high concentration of oxygen (7 L/min) was needed on admission. However, these treatments did not have enough effect on his clinical course, as revealed by the laboratory data with persistent leukocytosis and elevated CRP level (Fig. 2) . Thus, after day 7, subcutaneous interferon (IFN)-c (2.5 9 10 5 units/m 2 ) was administered 3 times a week for the first week and once a week for the next 6 weeks. After the start of IFN-c therapy, the white blood count and CRP value dropped (Fig. 2) , and the consolidations in the bilateral lung fields on the CT scan markedly improved on day 13 (Fig. 1c) . The oxygen was tapered off over 10 days. The patient was discharged on day 13. The pulmonary consolidations on the CT scan were further improved on day 36 (Fig. 1d ).
Materials and methods

Isolation of neutrophils
Human neutrophils were isolated from the peripheral blood of a healthy adult volunteer and the CGD patient by sedimentation through a 2-step Percoll gradient, as previously described [7] . The healthy volunteer and CGD patient provided written informed consent for participation in an institutional review board-approved protocol at Kyoto University Hospital.
ROS generation of neutrophils before and after the IFN-c treatment by flow cytometry Neutrophils (2 9 10 5 cells) were loaded with 2 lM dihydrorhodamine 123 (DHR, Molecular Probes) for 5 min at 37°C. After that, cells were stimulated with 100 ng/ml phorbol myristate acetate (PMA, Sigma-Aldrich) for 15 min at 37°C and analyzed by flow cytometry.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA from neutrophils was isolated using Trizol (Invitrogen). Total RNA (1 lg) was reverse-transcribed using the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen) following the manufacturer's instructions. PCR for a portion of CYBB alleles was performed using the following primers: P1 (5 0 -TGCCAC CATGGGGAACTGGGCTGTGAATGAG-3 0 ) on exon 1 and P2 (5 0 -GTACCAAAAGACTTCAAAGTAAGACCT CCGGATG-3 0 ) on exon 6. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used to monitor RNA recovery. The PCR was performed under the following conditions: 94°C for 2 min followed by 40 cycles of 94°C for 30 s, 63°C for 45 s and 72°C for 1 min.
ROS generation by Nox2 mutants lacking exon 3
The wild-type Nox2, named wt Nox2(1-13), was constructed by inserting the cDNA fragment containing the entire open reading frame of human Nox2, which consists of 13 exons, inframe into pcDNA3.1. A series of Nox2 mutants lacking exon 3 were generated by inserting the relevant exon regions inframe into pcDNA3.1. These deletions were as follows: Nox2(1,2,4-13)(exon 1, exon 2 and exons 4-13), Nox2 (1,4-13)(exon 1 and exons 4-13), Nox2(1,4,6-13)(exon 1, exon 4 and exons 6-13), Nox2(1,6-13)(exon 1 and exons 6-13) and Nox2(1,7-13)(exon 1 and exons 7-13). ROS generation from HEK293 (ATCC) cells transfected with wild-type Nox2 or mutant Nox2 in combination with p47 phox and p67 phox was measured by a luminol-enhanced chemiluminescence method in the presence of horseradish peroxidase (HRP) and luminol, as previously described [8] .
Results and discussion
The intensity of DHR fluorescence of CGD neutrophils immediately before IFN-c treatment (day 7) upon stimulation with PMA apparently diminished compared with that of healthy neutrophils (Fig. 3a, b, d ). After IFN-c treatment (day 50), CGD neutrophils showed a higher intensity of DHR fluorescence by PMA stimulation, which was similar to that of healthy neutrophils (Fig. 3b, c, d ), suggesting that IFN-c treatment augmented the ROS production of CGD neutrophils in vivo. This finding was compatible with a previous report, where the authors demonstrated the effect of IFN-c in vivo on CGD patients under healthy conditions [3] . By contrast, in our case, the therapeutic effectiveness of IFN-c was observed in a CGD patient complicated with IPA, where it possibly contributed to the clinical improvement by the enhancement of microbicidal activity. In order to clarify the mechanism of how IFN-c enhanced the activity of ROS production in our CGD neutrophils, we analyzed the ROS production from HEK293 cells transfected with plasmid containing various types of mutant Nox2, which lack exon 3. The mutation in our patient was a G to A silent mutation (Ala to Ala) at nucleotide 252 in exon 3. However, this mutation site is adjacent to the splice junction, making splicing-variant transcripts skipping exon 3 [3] . Nunoi et al. proposed the hypothesis that IFN-c corrects a part of aberrant splicing of transcripts in the progenitor cells, which can produce ROS to some extent, and induces a prolonged effect on ROS generation activity. Thereby, a considerable amount of the corrected progenitor cells produce mature neutrophils with functional gp91 phox in CGD patients with this mutation [3, 9] . In our experiment, none of the HEK293 cells transfected with mutant Nox2, which lack exon 3, showed any significant ROS generation in response to PMA stimulation as revealed by luminol-enhanced chemiluminescence method. Only HEK 293 cells transfected with wild-type Nox2 [wt Nox2(1-13)] could produce ROS upon stimulation with PMA, which was suppressed by the addition of diphenyleneiodonium (DPI), a Nox inhibitor (Fig. 4) . Furthermore, in vitro administration of IFN-c did not directly affect the ROS production of neutrophils from the CGD patient (data not shown). On the other hand, we performed RT-PCR analysis for CYBB gene transcripts from patient's neutrophils under favorable health conditions. The amplified transcripts using primers on exon 1 and exon 6 exhibited a 518-bp band that lacked exon 3 (Fig. 5a, b, c) [3] . Unfortunately, we were not able to check the splicing-variant transcripts of the patient's neutrophils immediately before and after IFN-c treatment, since the quality of RNAs obtained was not favorable. However, the mutation in our case is exactly the same as the one in the previous report by Ishibashi et al. [3] , it is rational to assume that the similar splicing events had happened after IFN-c treatment. Based on these findings, we speculate that IFN-c, at least in part, precluded the exon 3 skipping in the progenitor cells. As a result, a considerable amount of neutrophils derived from the progenitor cells may have generated a full-length transcript of Nox2, irrespective of the presence of G to A substitution in exon 3, and acquired the activity of ROS production. This speculation is supported by a report that -1 position (G) of splice donor consensus sequence (G/gt is 73 % of all splice donor site) is A/gt, T/gt and C/gt in 9, 12, and 6 %, in spite of 100 % universality at ?1 and ?2 positions (gt) [10] . It remains unclear why the patient's neutrophils produced a certain amount of ROS before treatment.
Many clinical observations in CGD patients provide evidence that ROS are important for killing Aspergillus hyphae [11, 12] . Neutrophils, which engulf Aspergillus hyphae in the phagosome, can kill them efficiently in a ROS-dependent manner. Recently, neutrophil extracellular traps (NETs), which capture bacteria, fungi, and viruses in extracellular structures consisting of DNA fibers and antimicrobial granule proteins, have been reported to play a pivotal role in innate host defense [13] . Previous reports show that CGD neutrophils are not able to make NETs, indicating that Nox activation of neutrophils is required for NET formation [14, 15] . The defect of NET formation in CGD neutrophils is likely to contribute to failure to kill Aspergillus, although we did not examine NET formation in this patient.
It has been reported that the oral administration of itraconazole is effective for prophylaxis against aspergillosis in CGD patients [16] . Unfortunately, our patient was affected with IPA, since he did not take itraconazole. Voriconazole is now the first choice for the treatment of aspergillosis; however, reports of multi-azole-resistant Aspergillus fumigatus have been accumulated [4, 17] . A previous report demonstrated that another cytokine, granulocyte colony stimulating-factor or granulocyte-macrophage colony stimulating-factor, enhanced the candidacidal activity of neutrophils in collaboration with voriconazole [18] , but it is unclear whether this is applicable to the killing activity of CGD neutrophils against Aspergillus. This study supports the idea that the in vivo enhancement of microbicidal activity in neutrophils by IFN-c administration is effective in CGD patients with intractable fungal infections. Fig. 4 ROS production from HEK293 cells transfected with the mutant Nox2, wt Nox2 or mock plasmid. Open, filled, and hatched bars show ROS production in the absence of PMA, the presence of PMA, and the presence of PMA and DPI, respectively. Note that only HEK293 cells transfected with the wt Nox2 plasmid generated ROS upon stimulation with PMA. Exons 4, 5, and 6 include His101, His115, and His209 ? His222 residues, respectively, which are essential for heme-binding. ROS production is expressed as the percentage of that in cells transfected with wt Nox2 in the presence of PMA Fig. 5 a Alignment of exon1 to 6 of CYBB gene. P1 and P2 are primers for RT-PCR. b Schematic representation of splicing pattern of CYBB gene transcripts in the CGD patient and healthy control. c RT-PCR analysis of total RNA from neutrophils using P1 and P2 primers. The CGD patient under favorable health conditions yielded a 518-bp amplification product that lacked exon 3, whereas the amplification product for healthy control was 629-bp Augmented ROS production by IFN-c in CGD 509
